BioCentury
ARTICLE | Financial News

CRISPR Therapeutics amends IPO

October 10, 2016 7:00 AM UTC

CRISPR Therapeutics AG, Basel, Switzerland Business: Gene/Cell therapy, Hematology, Pulmonary Date announced: 2016-10-07 Type: IPO To be raised: Up to $79.9 million Shares: 4.7 million Price: $15-$17 ...